Second Wave of Moves from SAC Capital

In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio. All five filings disclose significant reductions in their stakes and follow another round of changes announced earlier this week.

SAC CAPITAL ADVISORS

Cohen has decreased his fund’s exposure to Lumber Liquidators Holdings Inc (NYSE:LL) by almost a half. After SAC had reported an increase in its holding to 1.39 million shares, it has now decreased it to approximately 707,500 shares, which account for 2.6% of the company’s common stock. Lumber Liquidators is a retailer of hardwood flooring and accessories with a market cap of $2.64 billion.

Another stock, Cohen has decreased exposure to, is Tile Shop Hldgs, Inc. (NASDAQ:TTS), a retailer of stone tiles, setting and maintenance materials in the United States. SAC Capital has reduced its holding from 2.95 million to 1.6 million shares, according to a recent filing with the SEC. The current position accounts for 3.1% of the total number of shares outstanding.

Stemline Therapeutics Inc (NASDAQ:STML) is also part of the spring-cleaning program of Cohen. SAC Capital has reported a decrease in its stake to 353,000 shares or 2.7% of the company’s common stock. Stemline Therapeutics is a biopharmaceutical company, which focuses on the discovery and development of therapeutics that target cancer cells and tumor bulk. The company has a market cap of $252 million and does not pay a dividend.

SAC Capital has also reduced its investment in E-House (China) Holdings Limited (ADR) (NYSE:EJ). According to a recently amended filing, Cohen has decreased his fund’s holding from 7.55 million to 3.01 million shares, which account for 2.2% of the total number of shares outstanding. E-House (China) Holdings Limited is a real estate services company that operates in the People’s Republic of China.

Cohen has also dumped most of SAC Capital’s holding of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), leaving it with 6,123 shares which account for less than 0.1% of the total number of shares. Intercept Pharmaceuticals focuses on the development of treatments for chronic liver diseases. The company has a market cap of $5.97 billion and does not pay a dividend. The stock price of Intercept quadrupled earlier this year, amid positive results regarding the company’s liver-disease drug.

Disclosure: none.

Recommended reading:

Recent Changes in SAC Capital Advisors’ Equity Portfolio

Billionaire Steven Cohen Initiates Position in Midstates Petroleum Company Inc (MPO); Boosts Stake in Zynga Inc (ZNGA)

Steven Cohen Ups His Bets on NQ Mobile Inc (ADR) (NQ)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!